HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

carboxymethylcurdlan

Also Known As:

CM-CUD; CM-curdlan; carboxymethyl-curdlan; carboxymethylcurdlan hydrogen sulfate

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Glucans: 1624
    - beta-Glucans: 499
      - carboxymethylcurdlan: 1

Experts

1.	Bae, Y H: 1 article (11/2000)
2.	Kim, S W: 1 article (11/2000)
3.	Na, K: 1 article (11/2000)
4.	Park, K H: 1 article (11/2000)

Related Diseases

1.	Neoplasms (Cancer) 11/03/2000 - "It is concluded that LBA/CM-curdlan/SU hydrogel nanoparticles are a useful drug carrier for the treatment of liver cancer, because of the potential immunological enhancement activities of CM-curdlan in the body, the ligand-receptor mediated specific interactions, and the controlled release of the anti-cancer drug."
2.	Liver Neoplasms (Liver Cancer) 11/03/2000 - "It is concluded that LBA/CM-curdlan/SU hydrogel nanoparticles are a useful drug carrier for the treatment of liver cancer, because of the potential immunological enhancement activities of CM-curdlan in the body, the ligand-receptor mediated specific interactions, and the controlled release of the anti-cancer drug."
3.	Carcinoma (Carcinomatosis) 11/03/2000 - "For specific interaction with a hepatic carcinoma cell line (HepG2), CM-curdlan was additionally conjugated with lactobionic acid (LBA; galactose moiety) (5.5 LBA molecules per hundred glucose units). "

Related Drugs and Biologics

1.	Hydrogels
2.	Ligands
3.	Glucose (Dextrose)
4.	Galactose (Galactopyranose)
5.	Drug Carriers
6.	lactobionic acid (lactobionate)